课题基金 / 基金详情

High-resolution mapping of cancer immunity to predict response to therapy in HER2-positive breast cancer patients

High-resolution mapping of cancer immunity to predict response to therapy in HER2-positive breast cancer patients
高分辨率癌症免疫图谱可预测 HER2 阳性乳腺癌患者的治疗反应
批准号:
488259
负责人:
Dumeaux Vanessa
金额:
$4.55万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-02-01 至 2024-02-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Thisstudy focuses on a type of breast cancer known as HER2-positive which has a particularly aggressive nature and for which standard treatments give mixed results. Capitalizing on powerful emergent technologies, we will study how genesin individual immun
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金